Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

M28804

Sigma-Aldrich

2-(2-Methylaminoethyl)pyridine

97%

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
C8H12N2
CAS Number:
5638-76-6
Molecular Weight:
136.19
EC Number:
227-086-4
MDL number:
MFCD00006362
UNSPSC Code:
12352100
PubChem Substance ID:
24896774
NACRES:
NA.22

Assay

97%

refractive index

n20/D 1.518 (lit.)

bp

113-114 °C/30 mmHg (lit.)

density

0.984 g/mL at 25 °C (lit.)

SMILES string

CNCCc1ccccn1

InChI

1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3

InChI key

UUQMNUMQCIQDMZ-UHFFFAOYSA-N

Gene Information

human ... HRH1(3269) , HRH3(11255)

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H315,H319,H335

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

206.6 °F - closed cup

Flash Point(C)

97 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000259009
0000259010
0000217364
0000189808
BGBC5486V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

2-Pyridinemethanol 98%

Sigma-Aldrich

P66602

2-Pyridinemethanol

Mattis Bertlich et al.
Life sciences, 187, 17-21 (2017-08-19)
Betahistine is a histamine analogue that is used for the treatment of Menière's disease. Animal studies showed that it increases local blood flow in the stria vascularis. In terms of its mode of action, recent studies have prompted discussion of
Brahim Tighilet et al.
Frontiers in neurology, 9, 431-431 (2018-06-27)
This study is a pharmacokinetic (PK) and pharmacodynamics (PD) approach using betahistine doses levels in unilateral vestibular neurectomized cats (UVN) comparable to those used in humans for treating patients with Menière's disease. The aim is to investigate for the first
Hiroshi Ueno et al.
The Libyan journal of medicine, 15(1), 1808361-1808361 (2020-08-19)
The administration of therapeutic agents is difficult in many patients, such as patients with post-operative delirium or dementia or patients with schizophrenia, who are upset in an emergency room. Therefore, the development of a new method for administering therapeutic agents
Adriana Pontin Garcia et al.
Brazilian journal of otorhinolaryngology, 79(3), 366-374 (2013-06-08)
Virtual reality technology can provide a wide range of sensory stimuli to generate conflicts of varying degrees of complexity in a safe environment. To verify the effect of a virtual realitybased balance rehabilitation program for patients with Menière's disease. This
Burkhard Franz et al.
Acta oto-laryngologica, 131(11), 1155-1159 (2011-09-13)
Betahistine dihydrochloride, a drug used widely in the systemic treatment of balance disorders such as Ménière's disease, was found to improve eustachian tube function when applied topically in the nasopharynx of rats. The study tested the effect of betahistine, a
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service